Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach

Purpose To identify a structure to explain the relationship between socio-clinico factors, necessity-concerns beliefs, and perceived barriers to adherence with adjuvant endocrine therapy (AET) amongst women with breast cancer. Methods Participants were 244 patients with early-stage breast cancer rec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer research and treatment 2021-08, Vol.188 (3), p.779-788
Hauptverfasser: Tan, Eng Hooi, Wong, Andrea Li Ann, Tan, Chuan Chien, Wong, Patrick, Tan, Sing Huang, Ang, Li En Yvonne, Lim, Siew Eng, Chong, Wan Qin, Ho, Jingshan, Lee, Soo Chin, Tai, Bee Choo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To identify a structure to explain the relationship between socio-clinico factors, necessity-concerns beliefs, and perceived barriers to adherence with adjuvant endocrine therapy (AET) amongst women with breast cancer. Methods Participants were 244 patients with early-stage breast cancer recruited from two tertiary hospitals from May 2015 to December 2018 who completed questionnaires on medication adherence (Simplified Medication Adherence Questionnaire), necessity-concerns beliefs (Beliefs about Medicine Questionnaire), and barriers to adherence (Adherence Starts with Knowledge Questionnaire). Socio-clinico variables were collected via interview and medical records review. Structural equation modelling was applied to examine the relationships between these variables and possible mediating effects of necessity-concerns beliefs on adherence to AET. Results The median age of the study participants was 61 (range 32–80) years and the median duration on AET was 1.6 (IQR 1.2–2.6) years. Adherence was positively associated with age ( β  = 0.145, 95% CI: 0.011 to 0.279, p  = 0.034) and negatively associated with barriers ( β  = − 0.381, 95% CI: − 0.511 to − 0.251, p  
ISSN:0167-6806
1573-7217
DOI:10.1007/s10549-021-06204-9